MedTrace Logo

Acute Stroke Program of Interventions Addressing Racial and Ethnic Disparities

NCT00724555 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2005

Last updated 2014-01-31

No results posted yet for this study

Summary

The purpose of this study is to increase treatment of acute stroke with tissue plasminogen activator (tPA) across the District of Columbia. This study, however, will not evaluate tPA as an intervention.

Conditions

Sponsors & Collaborators

  • Medstar Health Research Institute

    collaborator OTHER

  • Howard University

    collaborator OTHER

  • George Washington University

    collaborator OTHER

  • University of Michigan

    collaborator OTHER

  • University of Wisconsin, Madison

    collaborator OTHER

  • Johns Hopkins University

    collaborator OTHER

  • University of Alabama at Birmingham

    collaborator OTHER

  • MedStar Good Samaritan Hospital

    collaborator UNKNOWN

  • Union Memorial Hospital

    collaborator OTHER

  • Georgetown University

    lead OTHER

Principal Investigators

  • Chelsea Kidwell, MD · Georgetown University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2013-01-31
Completion
2013-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00724555 on ClinicalTrials.gov